Please login to the form below

Not currently logged in
Email:
Password:

personalised medicines

This page shows the latest personalised medicines news and features for those working in and with pharma, biotech and healthcare.

Immuno-oncology, personalised medicine continues to drive pharma sector

Immuno-oncology, personalised medicine continues to drive pharma sector

Coming in after I-O and personalised medicines as the top most impactful trends was the growing role of  real-world evidence and a rise in the use of  electronic health ... Personalised medicines have been identified as key treatments by the UK’s

Latest news

More from news
Approximately 13 fully matching, plus 57 partially matching documents found.

Latest Intelligence

  • The dawn of a new era in medical education The dawn of a new era in medical education

    By Annlouise Pendse. We are living in a pivotal moment in medical history. The first wave of personalised medicines is now available and is changing the way diseases are identified and ... delivering often complex personalised medicine.

  • The first, my last, my everything The first, my last, my everything

    This growing empowerment arguably has its biggest impact in the arena of high-value medicines. ... We need a better understanding of patients. We’re heading rapidly towards personalised medicines, yet we’re still not personalising the value that we

  • Genomics integration: can the NHS rise to the challenge? Genomics integration: can the NHS rise to the challenge?

    We can then make sure personalised medicine treatment is targeted to the individual so they get the best treatment at the right point in time. ... Last year, NHS England announced that it will focus on earlier diagnosis and more personalised medicines

  • “Brexit has been a catalyst for UK clinical research... it’s turbocharged change” “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”

    National Institute for Health Research (NIHR) and the UK’s medicines regulator the MHRA. ... The partnership will aim to enable faster and more efficient drug research, generate more robust evidence to support treatment value, and ultimately provide

  • Cell and gene therapy Cell and gene therapy

    In the case of a personalised therapy like CAR-T, the cost of the raw materials, the components and the labour that goes into manufacturing, testing and logistics are all for ... For traditional biopharmaceutical products one batch equals many doses,

More from intelligence
Approximately 4 fully matching, plus 17 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics